✦ LIBER ✦

Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin

✍ Scribed by Chun-che Lin; Mei-chin Yin

Book ID: 113545481
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 183 KB
Volume: 28
Category: Article
ISSN: 0261-5614
DOI: 10.1016/j.clnu.2008.09.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxidative stress and antioxidant defense

Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy

✍ Görenek Levent; Acar Ali; Aydın Ahmet; Eyigun Can Polat; Çetinkaya Aytaç; Eken A 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 212 KB

Prevalence and impact of occult hepatiti

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca

Su1077 Vitamin D and B12 Supplementation

Su1077 Vitamin D and B12 Supplementation and Sustained Virologic Response in Chronic Hepatitis C Patients Treated With Pegylated Interferon and Ribavirin

✍ Mihai, Catalina; Dranga, Mihaela; Drug, Vasile; Prelipcean, Cristina Cijevschi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 228 KB

Listeria monocytogenes Meningitis in a P

Listeria monocytogenes Meningitis in a Patient with Chronic Hepatitis C Infection, Treated by Interferon alfa and Ribavirin

✍ T. Vander; M. Medvedovsky; C. Hallevy; G. Golzman; Y. Herishanu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Indications and limitations for aged pat

Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy

✍ Tsugiko Oze; Naoki Hiramatsu; Takayuki Yakushijin; Kiyoshi Mochizuki; Masahide O 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 778 KB

Pharmacokinetics and enhanced PKR respon

Pharmacokinetics and enhanced PKR response in patients with chronic hepatitis C treated with pegylated interferon alpha-2b and ribavirin

✍ Y. Asahina; N. Izumi; N. Umeda; T. Hosokawa; K. Ueda; F. Doi; K. Tsuchiya; H. Na 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 599 KB